These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Diagnosis
62 results:

  • 1. csf3r mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
    Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discerning clinicopathological features of congenital neutropenia syndromes: an approach to diagnostically challenging differential diagnoses.
    Parisi X; Bledsoe JR
    J Clin Pathol; 2024 Aug; 77(9):586-604. PubMed ID: 38589208
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Germline
    Bochicchio MT; Micucci G; Asioli S; Ghetti M; Simonetti G; Lucchesi A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003211
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
    Gao J; Han S; Deng B; Deng Y; Gao X
    Ann Hematol; 2024 Aug; 103(8):2591-2600. PubMed ID: 37993585
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Analysis of
    Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of biomarkers related to sepsis diagnosis based on bioinformatics and machine learning and experimental verification.
    Wang Q; Wang C; Zhang W; Tao Y; Guo J; Liu Y; Liu Z; Liu D; Mei J; Chen F
    Front Immunol; 2023; 14():1087691. PubMed ID: 37449204
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
    Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
    Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Impact of
    Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
    Carreño-Tarragona G; Álvarez-Larrán A; Harrison C; Martínez-Ávila JC; Hernández-Boluda JC; Ferrer-Marín F; Radia DH; Mora E; Francis S; González-Martínez T; Goddard K; Pérez-Encinas M; Narayanan S; Raya JM; Singh V; Gutiérrez X; Toth P; Amat-Martínez P; Mcilwaine L; Alobaidi M; Mayani K; McGregor A; Stuckey R; Psaila B; Segura A; Alvares C; Davidson K; Osorio S; Cutting R; Sweeney CP; Rufián L; Moreno L; Cuenca I; Smith J; Morales ML; Gil-Manso R; Koutsavlis I; Wang L; Mead AJ; Rozman M; Martínez-López J; Ayala R; Cross NCP
    Blood Adv; 2023 May; 7(9):1672-1681. PubMed ID: 36375042
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Co-Occurring csf3r W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
    Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
    Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of csf3r Mutations in B-Lineage Acute Lymphoblastic leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.
    Rashid M; Alasiri A; Al Balwi MA; Alkhaldi A; Alsuhaibani A; Alsultan A; Alharbi T; Alomair L; Almuzzaini B
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573308
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
    Mendoza H; Podoltsev NA; Siddon AJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary varicella-zoster virus infection of the immunocompromised associated with acute pancreatitis and hemophagocytic lymphohistiocytosis: A case report.
    Bérar A; Ardois S; Walter-Moraux P; Jegonday MA; Henriot B
    Medicine (Baltimore); 2021 Apr; 100(16):e25351. PubMed ID: 33879665
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. csf3r T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
    Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).
    Zhou YL; Wu LX; Peter Gale R; Wang ZL; Li JL; Jiang H; Jiang Q; Jiang B; Cao SB; Lou F; Sun Y; Wang CC; Liu YR; Wang Y; Chang YJ; Xu LP; Zhang XH; Liu KY; Ruan GR; Huang XJ
    Br J Haematol; 2020 Jul; 190(2):274-283. PubMed ID: 32103499
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.